Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 342.82B | 339.37B | 350.67B | 300.92B | 278.44B | 281.19B |
Gross Profit | 113.26B | 113.93B | 119.94B | 113.54B | 115.59B | 108.62B |
EBITDA | 28.49B | 37.87B | 48.06B | 52.66B | 30.53B | 24.31B |
Net Income | 16.38B | 16.18B | 21.21B | 20.77B | 10.57B | 8.98B |
Balance Sheet | ||||||
Total Assets | 437.47B | 437.47B | 399.17B | 362.44B | 306.92B | 283.88B |
Cash, Cash Equivalents and Short-Term Investments | 95.08B | 95.08B | 96.82B | 81.62B | 67.38B | 54.62B |
Total Debt | 47.80B | 47.80B | 44.56B | 53.75B | 43.75B | 38.77B |
Total Liabilities | 157.00B | 157.00B | 143.86B | 137.88B | 115.38B | 102.56B |
Stockholders Equity | 228.67B | 228.67B | 203.95B | 180.42B | 156.88B | 147.76B |
Cash Flow | ||||||
Free Cash Flow | 11.18B | 9.97B | 34.86B | 1.61B | 13.19B | -377.00M |
Operating Cash Flow | 11.18B | 29.18B | 45.48B | 16.38B | 27.10B | 11.74B |
Investing Cash Flow | 0.00 | -19.99B | -10.47B | -10.40B | -6.74B | -3.69B |
Financing Cash Flow | 0.00 | -13.45B | -22.21B | 4.13B | -1.51B | -11.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ¥231.77B | 14.30 | 2.61% | 6.87% | 1.26% | ||
65 Neutral | $26.93B | 15.26 | -4.27% | 3.16% | 1.02% | 1.89% | |
$19.14B | 15.61 | 7.40% | 2.66% | ― | ― | ||
$2.85B | 113.46 | 0.85% | 2.29% | ― | ― | ||
$10.88B | 29.53 | 4.91% | 3.60% | ― | ― | ||
$3.77B | 105.93 | 2.87% | 0.68% | ― | ― | ||
$9.33B | 16.08 | 7.61% | 0.02% | ― | ― |